Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 259

Similar articles for PubMed (Select 5477307)

1.

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

Andén NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U.

Eur J Pharmacol. 1970;11(3):303-14. No abstract available.

PMID:
5477307
2.

Mode of action of L-DOPA on central noradrenaline mechanisms.

Andén NE, Engel J, Rubenson A.

Naunyn Schmiedebergs Arch Pharmacol. 1972;273(1):1-10. No abstract available.

PMID:
4260802
3.

The neuroleptics. 6. Clinical and experimental electroencephalography.

Borenstein P, Dongier M, Fink M, Florio V, Itil TM, Longo VG, Mellerio F, Naquet R, Pampiglione G, Titeca J, Verdeaux G.

Mod Probl Pharmacopsychiatry. 1970;5:109-25. No abstract available.

PMID:
5005609
4.

[l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].

Degkwitz R.

Med Klin. 1969 Aug 15;64(33):1451-6. Review. German. No abstract available.

PMID:
4896563
5.

[The antipsychotic action of neuroleptics and basal ganglia function].

Arushanian EB.

Farmakol Toksikol. 1973 Jul-Aug;26(4):481-9. Review. Russian. No abstract available.

PMID:
4151298
6.

Effects of clozapine on cerebral catecholaminergic neurone systems.

Bartholini G, Haefely W, Jalfre M, Keller HH, Pletscher A.

Br J Pharmacol. 1972 Dec;46(4):736-40.

7.

Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system.

Andén NE, Stock G.

J Pharm Pharmacol. 1973 Apr;25(4):346-8. No abstract available.

PMID:
4146695
8.
9.

[Neuroleptics--phenothiazine and butyrophenone derivatives].

Vetulani J.

Postepy Hig Med Dosw. 1969 Sep-Oct;23(5):661-705. Review. Polish. No abstract available.

PMID:
4908589
10.

Some observations on the site of action of oxypertin.

Fuxe K, Grobecker H, Hökfelt T, Jonsson J, Malmfors T.

Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967;256(4):450-63. No abstract available.

PMID:
5622482
11.

Evidence that methadone blocks dopamine receptors in the brain.

Sasame HA, Perez-Cruet J, Di Chiara G, Tagliamonte A, Tagliamonte P, Gessa GL.

J Neurochem. 1972 Aug;19(8):1953-7. No abstract available.

PMID:
4538006
13.

Drugs affecting monoamines in the basal ganglia.

Bartholini G, Pletscher A.

Adv Biochem Psychopharmacol. 1972;6:135-48. Review. No abstract available.

PMID:
4560163
14.

Identification of dopamine, noradrenaline and 5-hydroxytryptamine varicosities in a fraction containing nerve ending particles.

Fuxe K, Grobecker H, Hökfelt T, Jonsson G.

Brain Res. 1967 Nov;6(3):475-80. No abstract available.

PMID:
6076252
15.

Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?

Matthysse S.

Fed Proc. 1973 Feb;32(2):200-5. Review. No abstract available.

PMID:
4348519
16.

Evidence for a central noradrenaline receptor stimulation by clonidine.

Andén NE, Corrodi H, Fuxe K, Hökfelt B, Hökfelt T, Rydin C, Svensson T.

Life Sci. 1970 May 1;9(9):513-23. No abstract available.

PMID:
4393798
17.

Histological and molecular biochemistry.

Andén NE, Bartholini G, Corrodi H, Csillik B, De Robertis E, Dresse A, Fuxe K, Gerebtzoff MA, Glowinski J, Hansson E, Hökfelt T, Renson J, Roos BE.

Mod Probl Pharmacopsychiatry. 1970;5:1-11. No abstract available.

PMID:
4348145
18.

Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.

Andén NE, Engel J.

Adv Neurol. 1974;5:317-24. No abstract available.

PMID:
4613158
19.

The effects of L-3,4-dihydroxyphenylalanine on spinal reflex activity.

Baker RG, Anderson EG.

J Pharmacol Exp Ther. 1970 May;173(1):212-23. No abstract available.

PMID:
5442299
20.

Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.

Andén NE, Strömbom U.

Psychopharmacologia. 1974;38(2):91-103. No abstract available.

PMID:
4533319
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk